Disease Models, Animal
Recent clinical, regulatory, research and industry developments relating to this disease.
Prime editing-installed suppressor tRNAs for disease-agnostic genome editing.
An integrative systems-biology approach defines mechanisms of Alzheimer's disease neurodegeneration.
Regulating the Plasticity of Hippocampal Neurons via Electroacupuncture in Depression Model Mice.
In vivo base editing extends lifespan of a humanized mouse model of prion disease.
NMDA Receptors in Neurodevelopmental Disorders: Pathophysiology and Disease Models.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- Active recent publication activity, including 3 notable findings.
Research HighlightsViewHide
- 2026-04-15Wireless electrostimulation implants enable sphincter neuromuscular improvement toward mixed urinary incontinence.Zheng T · 2026
- 2026-01-21Magnetically Responsive Piezoelectric Nanocapacitors Enhance Neural Recovery Following Spinal Cord Injury via Targeted Spinal Magnetic Stimulation.Xiao Z · 2026
- 2025-11-19Prime editing-installed suppressor tRNAs for disease-agnostic genome editing.Pierce SE · 2025
- 2025-09-17Alpha-Ketoglutarate Ameliorates Synaptic Plasticity Deficits in APP/PS1 Mice Model of Alzheimer's Disease.Navakkode S · 2025
- 2025-09-12A rare genetic variant confers resistance to neurodegeneration across multiple neurological disorders by augmenting selective autophagy.Croce KR · 2025
- 2025-10-06Optogenetic stimulation of midbrain dopaminergic neurons rescues hippocampal synaptic plasticity deficits in a mouse model of Alzheimer's disease.Ficchì S · 2025
- 2026-04-15ResearchWireless electrostimulation implants enable sphincter neuromuscular improvement toward mixed urinary incontinence.Zheng T · 2026
- 2026-01-21ResearchMagnetically Responsive Piezoelectric Nanocapacitors Enhance Neural Recovery Following Spinal Cord Injury via Targeted Spinal Magnetic Stimulation.Xiao Z · 2026
- 2025-11-19ResearchPrime editing-installed suppressor tRNAs for disease-agnostic genome editing.Pierce SE · 2025
- 2025-10-06ResearchOptogenetic stimulation of midbrain dopaminergic neurons rescues hippocampal synaptic plasticity deficits in a mouse model of Alzheimer's disease.Ficchì S · 2025
- 2025-09-17ResearchAlpha-Ketoglutarate Ameliorates Synaptic Plasticity Deficits in APP/PS1 Mice Model of Alzheimer's Disease.Navakkode S · 2025
- 2025-09-12ResearchA rare genetic variant confers resistance to neurodegeneration across multiple neurological disorders by augmenting selective autophagy.Croce KR · 2025
Research-associated treatments
Drugs and agents co-studied with this disease across the research literature — associative, not necessarily established treatments. Number shows shared papers.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Alzheimer Disease44
- Neuronal Plasticity21
- Neurons18
- Cognitive Dysfunction13
- Gastrointestinal Microbiome12
- Hippocampus12
- Neurodegenerative Diseases9
- Synapses9
Leading journals6
- Nature communications38
- The Journal of neuroscience : the official journal of the Society for Neuroscience15
- International journal of molecular sciences10
- Nature10
- Molecular psychiatry9
- The Journal of clinical investigation9
Leading researchers8
- Li Y15
- Wang Y15
- Zhang X12
- Zhang Y12
- Wang J11
- Chen X9
- Chen Y9
- Liu Y9
Affiliations (unnormalised)6
- University of California15
- School of Medicine10
- Department of Laboratory Medicine5
- Hope Center for Neurological Disorders5
- Icahn School of Medicine at Mount Sinai5
- Massachusetts Institute of Technology5
Disease biology
Key proteins & gene products studied in this disease. Number shows shared papers.
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Disease profile
A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.
Disease models, animal are naturally occurring or experimentally induced diseases in animals that show pathological processes analogous to human diseases. They are used as experimental systems to study disease biology and to support translational research.
The grounding supports two broad origins: naturally occurring disease in animals and experimentally induced disease. No specific aetiologies beyond those categories are provided.
The supplied literature grounding does not define a single disease mechanism for animal disease models as a category. It indicates that these models are used to study diverse biological processes such as neuronal plasticity, signal transduction, oxidative stress, long-term potentiation, cognition, behavior, gastrointestinal microbiome, and immune-related pathways.
The grounding does not provide risk factors for this category as a disease entity. It only indicates that animal disease models may be naturally occurring or experimentally induced.
The grounding does not support a standard clinical treatment for disease models, animal as a category. The literature instead describes their use as research platforms for preclinical drug evaluation, biomarker identification, biologic studies, and translational research.
AI-generated summary grounded in MeSH and 6 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-06.
Reference
Authoritative identity, definition & identifiers.
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.